January 17, 2025

Patient Care Declines After PE Acquisition

A recent study reveals that patient-reported care experience declined significantly at hospitals acquired by private equity firms, highlighting the potential impact of private equity acquisitions on patient care.

Conexiant

January 16, 2025

Vertigo, Emesis, Auditory Impairment: What's Your Diagnosis?

A patient presents with sudden-onset right-sided otalgia accompanied by vertigo, emesis, and auditory impairment. Your otoscope reveals an unexpected finding. What's your diagnosis?

Conexiant

January 16, 2025

New XLH Guidelines Shift Primary Therapy to Burosumab

"Burosumab treatment normalized ALP serum levels in about 80% of both pediatric and adolescent cohorts, suggesting a substantial improvement of rickets in these patients," report authors of comprehensive new evidence-based recommendations for X-linked hypophosphatemia management.

Conexiant

January 16, 2025

Bone Density Risks in Cancer Survivors

Discover how cancer treatments, lifestyle factors, and comorbidities contribute to long-term bone mineral density deficits in childhood cancer survivors.

Conexiant

January 15, 2025

Bertagnolli to Exit NIH Director Role

NIH director, Dr. Monica M. Bertagnolli, is stepping down after launching major initiatives in women's health and long COVID research, indicating optimism for their continuation under new leadership.

Conexiant

January 15, 2025

Achalasia: Candida's Role in Cancer Risk

New study links esophageal Candida infection to significant cancer risk increase in achalasia patients.

Conexiant

January 15, 2025

PRKG2: Genetic Link Between SSc and LUAD

PRKG2 expression reveals genetic ties between systemic sclerosis and lung adenocarcinoma.

Conexiant

January 15, 2025

Cutaneous Head and Neck Melanoma: Better Outcomes with ICIs

Explore the distinct clinicopathological features and treatment outcomes of cutaneous head and neck melanoma versus other melanoma sites.

Conexiant

January 14, 2025

Genetic Mutations in ANO3 Linked to Dystonia

Dysregulated Ca²⁺ signaling due to ANO3 mutations impairs K⁺ channel activation in striatal neurons, offering new insights into the pathophysiology of dystonia.

Conexiant